Ryan M. Carnahan, PharmD: The Relationship of an Anticholinergic Rating Scale With Serum Anticholinergic Activity in Elderly Nursing Home Residents

Name: Ryan M. Carnahan, PharmD: The Relationship of an Anticholinergic Rating Scale With Serum Anticholinergic Activity in Elderly Nursing Home Residents
SKU: 3043
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 36 No. 4 Articles Tags: anticholinergic, brian-c-lund, bruce-g-pollock, delirium, elderly, kennith-r-culp, paul-j-perry, pharmd, radioreceptor-assay, ryan-m-carnahan, serum-anticholinergic-activity

Description

Ryan M. Carnahan, PharmD: The Relationship of an Anticholinergic Rating Scale With Serum Anticholinergic Activity in Elderly Nursing Home Residents

Description

Ryan M. Carnahan, PharmD

DRUG DISPOSITION & PHARMACOKINETICS

The Relationship of an Anticholinergic Rating Scale With Serum Anticholinergic Activity in Elderly Nursing Home Residents

Ryan M. Carnahan, PharmD, Brian C. Lund, PharmD, MS, BCCP, Paul J. Perry, PhD, Kennith R. Culp, PhD, and Bruce G. Pollock, MD, PhD

Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial

VOL 3 No. 3 Full Issue – March 2001

Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia

Ryan M. Carnahan, PharmD: A Critical Appraisal of the Utility of the Serum Anticholinergic Activity Assay in Research and Clinical Practice

Ryan M. Carnahan, PharmD: The Relationship of an Anticholinergic Rating Scale With Serum Anticholinergic Activity in Elderly Nursing Home Residents

Description

Ryan M. Carnahan, PharmD

DRUG DISPOSITION & PHARMACOKINETICS

The Relationship of an Anticholinergic Rating Scale With Serum Anticholinergic Activity in Elderly Nursing Home Residents

Ryan M. Carnahan, PharmD, Brian C. Lund, PharmD, MS, BCCP, Paul J. Perry, PhD, Kennith R. Culp, PhD, and Bruce G. Pollock, MD, PhD

Related products

Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial

VOL 3 No. 3 Full Issue – March 2001

Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia

Ryan M. Carnahan, PharmD: A Critical Appraisal of the Utility of the Serum Anticholinergic Activity Assay in Research and Clinical Practice